“Suppletion of oral dextrose gel is inexpensive, the dose easy to adjust to body weight and it’s simple to administer. Dextrose gel should be considered for first-line management of hypoglycaemia in late preterm and term babies in the first 48 hours after birth.”(1)
Following these scientific studies, BioProNeo B.V. has been requested by the neonatology department of Erasmus Sophia Children’s Hospital in Rotterdam, The Netherlands, to supply a dextrose gel easily applicable in neonates and dosable per kg bodyweight.
BioProNeo B.V. has specifically developed DexProNeo for this purpose.
DexProNeo is a 40% dextrose gel without preservatives in 6 ml sterile syringes and the desired dose can easily be applied.
- Ready to administer
- Easy to use
- Time & cost saving
- No preservatives
- Safe: the syringe is for buccal dosing only as connection to IV-tubings is NOT possible
“Use of buccal dextrose gel reduces hospital costs for management of neonatal hypoglycaemia. Because it is also non-invasive, well tolerated, safe, and associated with improved breastfeeding, buccal dextrose gel should be routinely used for initial treatment of neonatal hypoglycaemia.” (2)
1 Harris, D., Weston, P., Signal, M., Chase, J., & Harding, J. (2013). Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double blind, placebo-controlled trial. The Lancet, 382: 2077-2083.
2 Glasgow, M. J., Harding, J. E., Edlin, R., Study, T. f., Alsweiler, J., Chase, J. G., . . . CHYLD. (2018). Cost Analysis of Treating Neonatal Hypoglycemia with Dextrose Gel. The Journal of Pediatrics, 10.1016/j.jpeds.2018.02.036.